Your browser is no longer supported. Please, upgrade your browser.
Settings
NUVA NuVasive, Inc. daily Stock Chart
NUVA [NASD]
NuVasive, Inc.
Index- P/E112.08 EPS (ttm)0.48 Insider Own0.50% Shs Outstand49.43M Perf Week0.73%
Market Cap2.66B Forward P/E27.99 EPS next Y1.92 Insider Trans-14.15% Shs Float49.14M Perf Month4.14%
Income25.80M PEG7.68 EPS next Q0.36 Inst Own- Short Float7.18% Perf Quarter30.14%
Sales833.80M P/S3.19 EPS this Y453.30% Inst Trans1.01% Short Ratio4.57 Perf Half Y4.20%
Book/sh13.00 P/B4.14 EPS next Y27.62% ROA1.90% Target Price58.69 Perf Year10.29%
Cash/sh6.32 P/C8.51 EPS next 5Y14.60% ROE3.80% 52W Range36.81 - 56.61 Perf YTD-0.57%
Dividend- P/FCF52.04 EPS past 5Y-6.00% ROI- 52W High-4.96% Beta1.04
Dividend %- Quick Ratio3.80 Sales past 5Y11.10% Gross Margin75.60% 52W Low46.16% ATR1.24
Employees1600 Current Ratio5.40 Sales Q/Q11.80% Oper. Margin11.50% RSI (14)60.45 Volatility1.64% 2.58%
OptionableYes Debt/Eq1.04 EPS Q/Q-129.30% Profit Margin3.10% Rel Volume0.33 Prev Close54.15
ShortableYes LT Debt/Eq1.04 EarningsApr 26 AMC Payout0.00% Avg Volume771.56K Price53.80
Recom2.00 SMA201.29% SMA506.42% SMA2008.24% Volume257,200 Change-0.65%
Dec-11-15Upgrade BofA/Merrill Underperform → Neutral
Oct-06-15Upgrade Canaccord Genuity Hold → Buy $52 → $58
Sep-14-15Initiated Morgan Stanley Equal-Weight $60
Jul-29-15Upgrade Northland Capital Market Perform → Outperform $68
Jul-29-15Reiterated Barclays Equal Weight $54 → $56
Jun-03-15Downgrade Goldman Buy → Neutral
May-14-15Initiated Northland Capital Market Perform $46
Apr-15-15Downgrade Canaccord Genuity Buy → Hold $54 → $49
Feb-25-15Reiterated Brean Capital Buy $53 → $55
Jan-13-15Reiterated WallachBeth Buy $49 → $55
Jan-08-15Upgrade RBC Capital Mkts Sector Perform → Outperform $45 → $56
Dec-04-14Reiterated Brean Capital Buy $44 → $53
Sep-30-14Upgrade Brean Capital Hold → Buy $44
May-21-14Downgrade Needham Buy → Hold
Apr-30-14Reiterated RBC Capital Mkts Sector Perform $35 → $39
Apr-30-14Reiterated Canaccord Genuity Buy $51 → $48
Jan-22-14Reiterated Canaccord Genuity Buy $34 → $51
Jan-16-14Reiterated Barclays Equal Weight $35 → $38
Jan-09-14Reiterated Barclays Equal Weight $32 → $35
Dec-02-13Reiterated Barclays Equal Weight $30 → $32
May-25-16 06:28AM  Abaxis (ABAX) Posts Solid Q4 amid International Headwind
May-24-16 11:07AM  IHIs Mid Caps on May 19: Medtronics Deal with Mazor Pressures Globus
May-23-16 07:00AM  NuVasive Launches Next Generation Biologics Technology Marketwired
May-20-16 05:08PM  NUVASIVE INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders
May-13-16 07:00AM  NuVasive to Feature Game-Changing, Integrated Spine Solutions at SpineWeek 2016 Marketwired
May-12-16 08:18AM  Boston Scientific (BSX): Q1 Earnings Beat amid CRM Woes Zacks
May-05-16 04:05PM  NuVasive to Participate in Investor Event in May 2016 Marketwired
Apr-30-16 01:04PM  NUVASIVE INC Financials
Apr-28-16 07:00AM  NuVasive Extends Spine Innovator Leadership Position, Launches New Solutions at 84th AANS Annual Scientific Meeting Marketwired
Apr-27-16 12:03PM  NuVasive (NUVA) Tops Q1 Earnings, Grows Internationally +5.34%
02:03AM  Edited Transcript of NUVA earnings conference call or presentation 26-Apr-16 8:30pm GMT
Apr-26-16 05:45PM  NuVasive Rides Its Spinal Surgery Business Higher at Motley Fool
04:55PM  NuVasive reports 1Q loss AP
04:30PM  NuVasive Inc Earnings Call scheduled for 4:30 pm ET today CCBN
04:26PM  NUVASIVE INC Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD Disclosure, Financial S EDGAR Online
04:05PM  NuVasive Reports First Quarter 2016 Financial Results Marketwired
07:07AM  Q1 2016 NuVasive Inc Earnings Release - After Market Close CCBN
Apr-11-16 09:40AM  NuVasive: International Outlook Strong, Spine Prospects Bright
Apr-06-16 04:05PM  NuVasive Announces Conference Call and Webcast of First Quarter 2016 Results Marketwired
Apr-04-16 03:00AM  NuVasive Launches Integrated Global Alignment (iGA(TM)) Platform at BritSpine 2016 Marketwired
Mar-29-16 11:03AM  ETFs with exposure to NuVasive, Inc. : March 29, 2016
Mar-28-16 11:45AM  NuVasive, Inc. :NUVA-US: Earnings Analysis: Q4, 2015 By the Numbers
Mar-18-16 10:15AM  4 Well-Known Health Care Stocks Are Potential Buyout Candidates at 24/7 Wall St.
Mar-16-16 04:42PM  NUVASIVE INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligatio
Mar-15-16 09:57AM  NuVasive, Inc. Value Analysis (NASDAQ:NUVA) : March 15, 2016
Mar-14-16 08:16AM  NuVasive, Inc. breached its 50 day moving average in a Bullish Manner : NUVA-US : March 14, 2016
Mar-11-16 06:22AM  NUVASIVE INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits
05:00AM  NuVasive, Inc. Announces Pricing of Offering of $550 Million of 2.25% Convertible Senior Notes Due 2021 Marketwired
Mar-10-16 02:35PM  NuVasive's Reline Approved in Japan, iGA Launch in Focus
Mar-09-16 04:18PM  NUVASIVE INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial Statements and E
04:05PM  NuVasive, Inc. Announces Proposed Offering of $550 Million of Convertible Senior Notes Due 2021 Marketwired
01:55PM  NuVasive Strong on Fundamentals, Growth Prospects in Spine
07:00AM  NuVasive Announces Regulatory Approval of Reline(TM) Posterior Fixation Technology in Japan Marketwired
Mar-07-16 04:37PM  NUVASIVE INC Files SEC form 8-K, Regulation FD Disclosure
04:31PM  NuVasive Announces Agreement to Acquire Brazilian Distributor Mega Surgical Marketwired
Feb-25-16 04:05PM  NuVasive to Participate in Investor Events in March 2016 Marketwired
Feb-18-16 10:43AM  NuVasive (NUVA) Is in Oversold Territory: What's Next?
10:15AM  NuVasive, Inc. Earnings Analysis: 2015 By the Numbers
Feb-16-16 04:15PM  NuVasive (NUVA) Outperforms Q4 on Strong Domestic Growth
Feb-12-16 11:35AM  NuVasive Tops Earnings in Q4; Positive on Ellipse Inclusion -6.46%
07:39AM  NuVasive Sees Faster Sales Growth Following Ellipse Acquisition at Motley Fool
01:59AM  Edited Transcript of NUVA earnings conference call or presentation 11-Feb-16 9:30pm GMT
Feb-11-16 05:33PM  NuVasive beats Street 4Q forecasts
05:00PM  NUVASIVE INC Files SEC form 8-K, Completion of Acquisition or Disposition of Assets, Creation of a Direct Financial O
04:30PM  NuVasive Inc Earnings Call scheduled for 4:30 pm ET today
04:06PM  NuVasive Elects Robert F. Friel and Donald J. Rosenberg to Board of Directors Marketwired
04:05PM  NuVasive Reports Fourth Quarter and Full Year 2015 Financial Results Marketwired
07:07AM  Q4 2015 NuVasive Inc Earnings Release - After Market Close
Feb-09-16 10:22AM  Term Sheet Tuesday, February 9 at Fortune
Feb-05-16 08:30AM  Qualitative Analysis Highlights These Top Stocks -- Steris, Wright Medical Group, Nxstage Medical, and NuVasive Accesswire -6.71%
Jan-26-16 04:22PM  NuVasive Announces Conference Call and Webcast of Fourth Quarter 2015 Results at noodls
04:05PM  NuVasive Announces Conference Call and Webcast of Fourth Quarter 2015 Results Marketwired
Jan-12-16 02:55PM  NuVasive expects to post $811M in 2015 sales at bizjournals.com
08:09AM  NuVasive, Inc. breached its 50 day moving average in a Bearish Manner : January 12, 2016
07:02AM  NUVASIVE INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
07:00AM  NuVasive Announces Select Preliminary Full-Year 2015 Financial Results and Reiterates 2016 Outlook Marketwired
Jan-07-16 04:05PM  NuVasive to Participate in Investor Event in January 2016 Marketwired
Jan-06-16 02:25PM  NuVasive Strengthens in Transformative Spine, Buys Ellipse
09:35AM  NuVasive Announces Acquisition Of Ellipse Technologies, Notes 'Potential To Become The Standard Of Care'
09:20AM  Fresh off Dayton announcement, NuVasive makes acquisition at bizjournals.com
Jan-05-16 04:18PM  NUVASIVE INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial Statements and E
04:15PM  NuVasive to Acquire Ellipse Technologies Marketwired
Dec-30-15 02:25PM  NuVasive: International Business Flourishes amid Currency Woes
Dec-16-15 10:04AM  NuVasive, Inc. Value Analysis (NASDAQ:NUVA) : December 16, 2015
Dec-15-15 09:05AM  NuVasive, Inc. breached its 50 day moving average in a Bearish Manner : December 15, 2015
Dec-11-15 11:30AM  Behind the Deal: Regional effort helped land $45M project at bizjournals.com
Dec-10-15 04:36PM  NUVASIVE INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits
02:00PM  NuVasive Announces Location for New State-of-the-Art Manufacturing Facility Marketwired
12:33PM  Medical company picks Dayton region for new $45 million manufacturing center at bizjournals.com
07:00AM  NuVasive Hosts 2015 Investor Day Marketwired
Dec-04-15 10:40AM  Final offer in place to lure medical manufacturing plant to Dayton region at bizjournals.com
08:25AM  NuVasive, Inc. breached its 50 day moving average in a Bearish Manner : December 4, 2015
Dec-01-15 04:43PM  Should You Buy Diamond Offshore Drilling Inc (DO)? at Insider Monkey
07:04AM  NUVASIVE INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits
07:00AM  NuVasive Appoints Jason D. Hanson as Executive Vice President, Strategy, Corporate Development and General Counsel Marketwired
Nov-30-15 01:53PM  Billionaire Israel Englanders Catapult Management Is Betting Big On These 5 Stocks for Q4 at Insider Monkey
06:30AM  Invuity Names Greg Lucier Chairman GlobeNewswire
Nov-26-15 09:23AM  Is NuVasive, Inc. (NUVA) A Good Stock To Buy? at Insider Monkey
Nov-21-15 12:02PM  Hedge Funds Are Dumping Franks International NV (FI) at Insider Monkey
Nov-12-15 03:39PM  Globus Medical Leads the IHI Mid-Cap Space
Nov-10-15 11:56AM  6 Medical Device Stocks to Buy If Ted Cruz Is Elected President at TheStreet
Nov-06-15 09:47AM  NuVasive, Inc. breached its 50 day moving average in a Bullish Manner : November 6, 2015
Oct-30-15 07:25PM  NuVasive Straightens Up Its Business With Strong Growth at Motley Fool
Oct-29-15 08:00AM  Strength Seen in Abaxis (ABAX): Stock Surges 23.4%
Oct-28-15 10:08AM  NuVasive Tops Q3 Earnings, Revenues; EPS View Up
Oct-27-15 11:12PM  Edited Transcript of NUVA earnings conference call or presentation 27-Oct-15 8:30pm GMT
05:07PM  NuVasive tops Street 3Q forecasts
04:30PM  NuVasive Inc Earnings Call scheduled for 4:30 pm ET today
04:15PM  NUVASIVE INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
04:05PM  NuVasive Reports Third Quarter 2015 Financial Results Marketwired
07:07AM  Q3 2015 NuVasive Inc Earnings Release - After Market Close
Oct-26-15 03:48PM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Involving Possible Breaches of Fiduciary Duty by the Board of NuVasive, Inc. Business Wire
Oct-21-15 12:40PM  Affymetrix Poised on Strategic Deals & Key Product Launches
11:30AM  St. Jude Medical Q3 Earnings Meet, Currency Woes Prevail
Oct-20-15 02:30PM  CVS Pharmacy: New Support Program for Healthcare Coverage
Oct-16-15 02:05PM  C.R. Bard (BCR) Set to Outshine Earnings Estimates in Q3
Oct-15-15 05:47PM  NuVasive, Basic Energy Services, Mariott Vacations Worldwide: Why Did These Three Stocks Get Slammed Today? at Insider Monkey
02:45PM  St. Jude Medical Presents Positive HeartMate PHP Trial Data
11:41AM  3 MedTech Stocks Poised to Trump Earnings in Q3
08:55AM  Why NuVasive (NUVA) Could Beat Earnings Estimates Again
NuVasive, Inc., a medical device company, develops and markets minimally-disruptive surgical products and procedurally-integrated solutions for spine surgery. Its products focus on applications for spine fusion surgery, including biologics used for spinal fusion process. The company's principal product is Maximum Access Surgery (MAS), a minimally-disruptive surgical platform, which includes its software-driven nerve detection and avoidance systems, NVM5, and intraoperative monitoring (IMO) services and support; MaXcess, an integrated split-blade retractor system; and various specialized implants and biologics. Its spine surgery product line offerings comprise products for the thoracolumbar and the cervical spine, which are primarily used to enable surgeons access to the spine and to perform restorative and fusion procedures in a minimally disruptive fashion. Its biologics products are used for spinal fusion or bone healing process, including Formagraft, a collagen-based synthetic bone substitute; AttraX, a synthetic bone graft material; Propel DBM, a moldable demineralized bone matrix putty; and Osteocel Plus and Osteocel Pro, an allograft (donated human tissue) cellular matrix. The company's IMO services are used for onsite and remote monitoring of the neurological systems of patients undergoing spinal and brain-related surgeries. It also provides implants; and fixation products, including pedicle screws, rods, and plates. In addition, the company offers Integrated Global Alignment platform for assessing, preserving, and restoring spinal alignment; MAGEC-early onset scoliosis (EOS), a spinal bracing and distraction system; and PRECICE, a limb lengthening system. NuVasive, Inc. sells its products to surgeons, hospitals, and other customer through independent sales agents, directly-employed sales forces, and distributors in the United States and internationally. The company was founded in 1997 and is headquartered in San Diego, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
BLAIR JACK RDirectorMay 19Option Exercise0.0011,892080,054May 23 06:00 PM
Miles PatrickPresident and COOMay 01Option Exercise0.005,600054,071May 03 06:08 PM
FARRELL PETER CDirectorFeb 18Option Exercise17.9014,000250,60021,627Feb 19 06:01 PM
BLAIR JACK RDirectorFeb 17Option Exercise18.3123,000421,15078,823Feb 18 06:00 PM
LUCIER GREGORY TChairman & CEOFeb 01Option Exercise0.0013,9980126,489Feb 03 06:19 PM
Miles PatrickPresident and COOFeb 01Option Exercise0.0033,653065,299Feb 03 06:20 PM
Link MatthewPresident, U.S. CommercialFeb 01Option Exercise0.0025,020088,015Feb 03 06:15 PM
Hannon JasonEVP, InternationalFeb 01Option Exercise0.0027,749046,314Feb 03 06:11 PM
Carol CoxEVP Ext Affairs & Corp MktgFeb 01Option Exercise0.001,92906,107Feb 03 06:09 PM
Blackford Quentin S.CFO and CAOFeb 01Option Exercise0.009,782015,959Feb 03 06:01 PM
Miles PatrickPresident and COOJan 06Sale54.0310,723579,34531,646Jan 07 04:11 PM
Miles PatrickPresident and COOJan 05Option Exercise38.9464,0282,493,25095,674Jan 07 04:11 PM
Miles PatrickPresident and COODec 16Sale52.569,127479,71531,646Dec 18 04:08 PM
Blackford Quentin S.CFO and CAODec 07Sale51.1015,000766,5002,599Dec 07 08:39 PM
Miles PatrickPresident and COODec 03Sale52.531,00052,53040,773Dec 03 05:33 PM
Miles PatrickPresident and COODec 02Option Exercise38.9485,9723,347,750113,726Dec 03 05:33 PM
Miles PatrickPresident and COODec 02Sale52.583,892204,64131,646Dec 03 05:33 PM
Miles PatrickPresident and COODec 01Sale52.1998151,19831,646Dec 03 05:33 PM
Miles PatrickPresident and COONov 02Sale48.1215,000721,80032,627Nov 04 04:11 PM
Link MatthewPresident, U.S. CommercialOct 05Sale50.721,71486,93453,089Oct 05 04:21 PM
Miles PatrickPresident and COOOct 01Sale48.1015,000721,50047,627Oct 05 04:12 PM
Powers RussellEVPSep 08Sale51.645,806299,82262,024Sep 10 04:12 PM
Hannon JasonEVP, Int'l and General CounselSep 02Sale51.971929,97818,565Sep 03 04:10 PM
Hannon JasonEVP, Int'l and General CounselSep 01Option Exercise38.9496,5083,758,022115,073Sep 03 04:10 PM
Hannon JasonEVP, Int'l and General CounselSep 01Sale52.0211,770612,27518,757Sep 03 04:10 PM
Miles PatrickPresident and COOSep 01Sale52.0315,000780,45062,627Sep 02 04:17 PM
Miles PatrickPresident and COOAug 31Option Exercise18.311392,54592,627Sep 02 04:17 PM
Miles PatrickPresident and COOAug 31Sale53.3415,000800,05477,627Sep 02 04:17 PM
Link MatthewPresident, U.S. CommercialAug 06Sale55.701,888105,16254,205Aug 10 04:14 PM
Hannon JasonEVP, Int'l and General CounselAug 03Option Exercise38.943,492135,97833,565Aug 05 04:10 PM
Hannon JasonEVP, Int'l and General CounselAug 03Sale54.7815,000821,70018,565Aug 05 04:10 PM
Powers RussellEVPJul 29Sale52.802,119111,88367,830Jul 31 04:09 PM
Hannon JasonEVP, Int'l and General CounselJul 20Sale49.6015,000744,00030,073Jul 22 04:30 PM
LUCIER GREGORY TChairman & CEOJun 12Buy49.975,000249,856108,000Jun 15 04:39 PM
LUCIER GREGORY TChairman & CEOJun 11Buy50.313,000150,923103,000Jun 15 04:39 PM
LUCIER GREGORY TChairman & CEOJun 10Buy49.935,000249,630100,000Jun 11 04:18 PM
LUCIER GREGORY TChairman & CEOJun 09Buy48.275,000241,36795,000Jun 11 04:18 PM
LUCIER GREGORY TChairman & CEOJun 08Buy49.365,000246,78690,000Jun 09 04:17 PM
LUCIER GREGORY TChairman & CEOJun 05Buy49.175,000245,83185,000Jun 09 04:17 PM
LUCIER GREGORY TChairman & CEOJun 04Buy49.675,000248,37280,000Jun 05 04:22 PM
LUCIER GREGORY TChairman & CEOJun 03Buy49.755,000248,74275,000Jun 05 04:22 PM
LUCIER GREGORY TChairman & CEOJun 02Buy49.855,000249,22970,000Jun 03 04:15 PM
Miles PatrickPresident and COOJun 02Sale49.474,194207,47792,488Jun 03 04:21 PM
Miles PatrickPresident and COOJun 01Option Exercise34.8229,0811,012,600121,569Jun 03 04:21 PM
LUCIER GREGORY TChairman & CEOJun 01Buy50.153,000150,46465,000Jun 03 04:15 PM
BLAIR JACK RDirectorMay 29Sale50.163,703185,74955,823Jun 01 05:19 PM
BLAIR JACK RDirectorMay 28Option Exercise19.006,000114,00061,823Jun 01 05:19 PM
LUCIER GREGORY TChairman & CEOMay 28Buy49.2534,0001,674,53162,000May 28 05:02 PM
Powers RussellEVP, InternationalMay 28Sale49.008,042394,05867,046Jun 01 05:26 PM